News
One of the best known communications executives in corporate America, Susman worked at Pfizer for nearly two decades after ...
In an exclusive interview, Sally Susman, a pioneer in corporate comms, recounts finding out that Pfizer's COVID-19 vaccine ...
According to Bloomberg, citing an email sent by Chief Executive Officer Albert Bourla on Tuesday, Susman’s responsibilities ...
9d
Axios on MSNSally Susman departs Pfizer after 18 yearsPfizer chief corporate affairs officer Sally Susman is departing the company after roughly two decades, CEO Albert Bourla ...
The Pfizer restructuring will be a case study in whether corporate restructuring & innovation can co-exist or whether M&A is the more viable answer, writes Edward Pratesi. The Pfizer restructuring ...
Pfizer has selected MacKay Jimeson and Niesha Foster as corporate affairs category leads after a reorganization of the company’s global innovative pharma business unit. The pharma giant recently ...
Pfizer Inc.’s new chief executive is preparing a restructuring plan that could include cutting several thousand jobs and changing the way the drug maker develops, makes and markets products, The ...
Pfizer sent sales and marketing executive Olivier Brandicourt to a Goldman Sachs conference Thursday to persuade investors that the drug maker is remaking itself in a hurry. Brandicourt was quite ...
NEW YORK (AP) — Pfizer lost $394 million in the fourth quarter as it booked billions in charges for layoffs and losses related to the acquisition of a trouble-plagued business ...
This is what we cannot help but wonder about Pfizer Inc. (NYSE: PFE) after the company announced on Monday that it is restructuring ... of a corporate break-up, and that is after Pfizer has ...
Pfizer plans to make this new organizational structure effective at the beginning of 2019. 2. Why Pfizer is restructuring . Pfizer mentioned two reasons for reorganizing into three business segments.
Pfizer lost $394 million in the fourth quarter as it booked billions in charges for layoffs and losses related to the acquisition of a trouble-plagued business that makes sterile injectable medicines.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results